MiR-663 was also shown to decrease glioblastoma by targeting transcripts encoding CXCR4, the receptor of chemokine CXCL12 that is known to be involved in glioblastoma progression, and miR-663 overexpression prolonged survival of mice with glioblastoma [62]. This evidence concerns the gene CXCL12 and glioblastoma.